why choose us

First received: April 18, 2023

Clinical Trial: [18F]FES PET/.CT in Uterine Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Uterine Cancer

Study Type: INTERVENTIONAL


Official Title: [18F]FLUOROESTRADIOL (FES) PET/CT IMAGING OF THE ESTROGEN RECEPTOR IN PATIENTS WITH METASTATIC OR RECURRENT UTERINE CANCER

Brief Summary: Women with known or suspected recurrent or metastatic uterine cancer may be eligible for this study.Patients may participate in this study if they are at least 18 years of age, most participants will be receiving care at the clinical practices of the University of Pennsylvania.[18F]fluoroestradiol (FES) PET/CT imaging will be used to evaluate estrogen receptor (ER) activity in areas of disease known by standard of care imaging (e.g.CT, MRI, Bone Scan, FDG PET/CT, ultrasound) or clinical exam.For patients…

Read more